Fabentech
Created in 2009
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
66 5,007 5,007Global tags
Activities
Technologies
Entity types
Location
24 Rue Jean Baldassini, 69007 Lyon, France
Lyon
France
Employees
Scale: 11-50
Estimated: 52
SIREN
512823972Engaged corporates
18
5 13Added in Motherbase
1 year, 8 months ago
biotech Value proposition
Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency.
In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications.
Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields of biodefense, drug intoxication and infectious disease.
After having developed Fabenflu®, a product indicated for the treatment of avian influenza (H5N1) in human, Fab’entech is currently focusing on 3 products: a biodefense antidote developed in collaboration with the French army, a treatment for drug intoxication developed in a confidential indication, and an Ebola therapy developed with the support of the European Commission after having been identified by the WHO as the unique therapeutic solution in Europe in 2014.
Immunotherapy, Polyclonal, Antibody, Antibodies, Emergency, Antidote, Antitoxin, Bioterrorism, Bioweapon, Poison, Infectious disease, Infectious diseases, Nosocomial, Emerging, Epidemic, Pandemic, Ebola, Drug abuse, and Narcotic dependenceOriginal language
Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency.
In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications.
Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields of biodefense, drug intoxication and infectious disease.
After having developed Fabenflu®, a product indicated for the treatment of avian influenza (H5N1) in human, Fab’entech is currently focusing on 3 products: a biodefense antidote developed in collaboration with the French army, a treatment for drug intoxication developed in a confidential indication, and an Ebola therapy developed with the support of the European Commission after having been identified by the WHO as the unique therapeutic solution in Europe in 2014.
Accueil - Fabentech
Fabentech est spécialisée dans le développement et la production de traitements d’urgence contre le bioterrorisme et les maladies infectieuses émergentes.
https://www.fabentech.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Auvergne-Rhône-Alpes Entreprises National and local authorities, Business Consulting and Services | Auvergne-Rhône-Alpes Entreprises National and local authorities, Business Consulting and Services | Other 26 Oct 2024 | | |
 European Parliament European Union, Political Organizations | European Parliament European Union, Political Organizations | Other 26 Sep 2024 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 13 Aug 2024 | | |
 Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 3 Jun 2024 | | |
 | Gouvernement | Other 28 Nov 2023 | | |
 Ministry of Economy Government Administration | Ministry of Economy Government Administration | Other 28 Nov 2023 | | |
 Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Other 9 Oct 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 28 Nov 2023 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 29 Oct 2024 | | |
 La French Tech Saint-Etienne Lyon French Tech, IT Services and IT Consulting | La French Tech Saint-Etienne Lyon French Tech, IT Services and IT Consulting | Other 13 Mar 2024 | | |